Part Number
Part Number:
NSN:
NIIN:
Item Name:
ASPIRIN DELAYED-RELEASE TABLETS ,
Definition:
CAGE Information
| Code | Company |
|---|---|
| 93544 | GLAXOSMITHKLINE HOLDINGS AMERICAS IN |
Federal Supply Class
Title
DRUGS AND BIOLOGICALS
Inclusions:
INCLUDES ALL DRUGS, MEDICINAL GRADE CHEMICALS, AND BIOLOGICALS SUBJECT TO THE FEDERAL FOOD, DRUG AND COSMETIC ACT, LISTED IN THE MONOGRAPH SECTION OF THE U.S. PHARMACOPEIA OR THE NATIONAL FORMULARY OR COVERED BY THE UNITED STATES ADOPTED NAMES (USAN). OTHER NATIONS MAY APPLY THEIR OWN LEGAL DOCUMENTS.
Exclusions:
EXCLUDES MEDICATED COSMETICS AND TOILETRIES CLASSIFIABLE IN FSC 6508 AND IN VITRO DIAGNOSTIC SUBSTANCES AND REAGENTS CLASSIFIABLE IN FSC 6550, AND VETERINARY DRUGS AND BIOLOGICALS CLASSIFIABLE IN FSC 6509.
Characteristics (Decoded)
| MRC | Requirements Statement | Clear Text Reply |
|---|---|---|
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 325.000 MILLIGRAMS ASPIRIN ACTIVE INGREDIENT |
| PKTY | UNIT PACKAGE TYPE | PACKAGE |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | ASPIRIN DELAYED-RELEASE TABLETS USP 325MG 250S 12S PER PG |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 250.000 TABLETS |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 12 |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| AJCN | PROTECTIVE STORAGE FEATURE | EXPIRATION DATED |
| CSGS | ADMINISTRATION | ORAL |